Abstract
Metformin has been suggested to possibly reduce cancer risk. However, the mechanism underlying the positive effects of metformin on cancer treatment remains unclear. We conducted a prospective study to evaluate the effects of preoperative metformin in patients with early breast cancer. We evaluated the effects on immunological factors (TILs, CD4 + , CD8 + , PD-L1, IFNγ and IL-2) by comparing core needle biopsies (CNB) obtained before metformin treatment with surgical specimens. Seventeen patients were enrolled in this prospective study from January to December 2016. We also analyzed 59 patients undergoing surgery during the same period to reveal the correlation of immune factors between CNB and surgical specimen. There was a moderate correlation between CNB and surgical specimens on TILs and CD8 + lymphocyte. (TILs Rs = 0.63, CD4 + Rs = 0.224, CD8 + Rs = 0.42) In the metformin group, TILs increases were confirmed in five (29%) patients, while a decrease was confirmed in two (12%). The expressions of CD4 + and CD8 + by TILs were increased in 41% and 18% of surgical specimens, respectively. However, TILs number (p = 0.0554), CD4+ (p = 0.0613) and CD8 + (p = 0.0646) expressions did not significantly increased. Furthermore, IFNγ ex...Continue Reading
References
Jun 1, 1997·Immunology Today·S Romagnani
Aug 30, 2000·Nature·C M PerouD Botstein
Jun 29, 2007·Journal of the National Cancer Institute·William J M HrusheskyRomano Demicheli
Jul 2, 2008·Breast Cancer Research and Treatment·Robin L JonesMitchell Dowsett
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe VialeUNKNOWN Breast International Group Trial 1-98
Feb 21, 2009·The New England Journal of Medicine·Christos Sotiriou, Lajos Pusztai
Feb 28, 2009·Breast Cancer Research and Treatment·Robin L JonesMitchell Dowsett
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaHope S Rugo
Sep 16, 2009·Cancer Research·Heather A HirschKevin Struhl
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertGunter von Minckwitz
Oct 14, 2010·Breast Cancer Research and Treatment·E J MacaskillJ M Dixon
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sahar M A MahmoudAndrew R Green
May 13, 2011·Breast Cancer Research and Treatment·Makiko OnoYasuhiro Fujiwara
Jun 10, 2011·Breast Cancer Research and Treatment·Sirwan HadadAlastair M Thompson
Jul 9, 2011·Nature Immunology·E John Wherry
Dec 5, 2012·Bone Marrow Transplantation·Y Kanda
Jan 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sherene LoiChristos Sotiriou
Jun 20, 2013·The Journal of Clinical Investigation·Chunyan Gu-TrantienKaren Willard-Gallo
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R SalgadoUNKNOWN International TILs Working Group 2014
Dec 17, 2014·PloS One·Yan MaoKunwei Shen
Dec 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertSibylle Loibl
Jan 28, 2015·Proceedings of the National Academy of Sciences of the United States of America·Shingo EikawaHeiichiro Udono
Apr 18, 2015·BMC Cancer·Federica BarbieriTullio Florio
Aug 22, 2015·Breast Cancer Research and Treatment·Kwang-Pil KoSue K Park
Apr 14, 2016·PloS One·Yan MaoKunwei Shen
Jul 2, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Carsten DenkertRoberto Salgado
Dec 13, 2016·Cancer Immunology Research·Nicole E ScharpingGreg M Delgoffe
Sep 25, 2017·Cancer Research·Lu ChenChristopher I Li
Jun 6, 2018·Breast Cancer Research and Treatment·Yoon Jin ChaJoon Jeong
Oct 17, 2018·Breast Cancer Research and Treatment·Hye Won HwangEun Yoon Cho
Oct 23, 2018·The New England Journal of Medicine·Peter SchmidUNKNOWN IMpassion130 Trial Investigators